Harris & Harris Group Announces the Filing of Preliminary Proxy Materials Detailing Its Proposed Conversion From a BDC to a Registered Closed-End Fund Jan 23, 2017
Harris & Harris Group Announces the Payoff of its Outstanding Credit Facility from ORIX Corporate Capital Dec 19, 2016
Harris & Harris Group Issues Letter to Shareholders and Information for Shareholder Call on Tuesday, November 15, 2016 Nov 14, 2016
Harris & Harris Group Issues Business Update and Reports Financial Statements as of September 30, 2016 Nov 9, 2016
Harris & Harris Group Portfolio Company, Mersana Therapeutics, Announces FDA Clearance of IND Application for Lead Antibody-Drug Conjugate XMT-1522 Oct 24, 2016
Harris & Harris Group Notes Announcements by Its Portfolio Companies During the Third Quarter of 2016 Sep 30, 2016
Harris & Harris Group to Host a Shareholder Update Call, Including a Presentation by One of Its Precision Health and Medicine Portfolio Companies, Muses Labs, Inc., on August 23, 2016 Aug 15, 2016
Harris & Harris Group Issues Business Update and Reports Financial Statements as of June 30, 2016 Aug 9, 2016
